* National Health Investors Inc NHI.N NHI is expected
to show
a fall in quarterly revenue when it reports results on February
22.
* The Murfreesboro Tennessee-based company is expected to
report
a 15.6% decrease in revenue to $68.568 million from $81.24
million a year ago, according to the mean estimate from 3
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for National Health
Investors
Inc is for earnings of 93 cents per share. For the same quarter
last year, the company reported earnings of 82 cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 6
"hold" and 1 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for National
Health
Investors Inc is $57, about 3.6% above its last closing price
of $54.97.
* Previous quarterly performance (using preferred earnings
measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Sep. 30 2021 1.18 1.21 1.15 Missed -5.2
Jun. 30 2021 1.23 1.26 1.16 Missed -8.2
Mar. 31 2021 1.33 1.34 1.24 Missed -7.5
Dec. 31 2020 1.41 1.41 1.37 Missed -2.8
Sep. 1.38 1.41 1.42 Beat 0.6
30 2020
Jun. 30 2020 1.43 1.43 1.46 Beat 2.2
Mar. 31 2020 1.39 1.39 1.36 Missed -2.4
Dec. 31 2019 1.40 1.40 1.41 Beat 0.4
This summary was machine generated February 18 at 21:51 GMT.
All figures in US dollars unless otherwise stated